Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head

International Journal of Gastrointestinal Cancer

Volumn 30, Issue 3, 2001, Pages 123-132

  Crane, Christopher H ^a   Antolak, John A ^a   Rosen, Isaac I ^a   Forster, Kenneth M ^a   Evans, Douglas B ^a   Janjan, Nora A ^a   Charnsangavej, Chusilp ^a   Pisters, Peter W T ^a   Lenzi, Renato ^a   Papagikos, Micheal A ^a   Wolff, Robert A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Conformal; Gemcitabine; IMRT; Pancreatic cancer; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COLLIMATOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEHYDRATION; DIARRHEA; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MAXIMUM TOLERATED DOSE; NAUSEA; NEUTROPENIA; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING;

EID: 0035786873     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:30:3:123     Document Type: Article

References (27)

1. The Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg 1979;189:205-208.
2. Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 1981;48:1705-1710.
3. Roldan GE, Gunderson LL, Nagorney DM, et al. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 1988;61:1110-1116.
4. Gunderson LL, Martin JK, Kvols LK, et al. Intraoperative and external beam irradiation +/-5-FU for locally advanced pancreatic cancer. Int J Rad Oncol Biol Phys 1987;13:319-329.
5. Mohiuddin M, Regine WF, Stevens J, et al. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol 1995;13:2764-2768.
6. Garton GR, Gunderson LL, Nagorney DM, et al. Highdose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer. Int J Rad Oncol Biol Phys 1993;27:1153-1157.
7. Shipley WU, Tepper JE, Warshaw AL, et al. Intraoperative radiation therapy for patients with pancreatic carcinoma. World J Surg 1984;8:929-934.
8. Shipley WU, Nardi GL, Cohen AM, et al. Iodine-125 implant and external beam irradiation in patients with localized pancreatic carcinoma: a comparative study to surgical resection. Cancer 1980;45:709-714.
9. Mohiuddin M, Cantor RJ, Biermann W, et al. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas. Int J Rad Oncol Biol Phys 1988;14:79-84.
10. Casper ES, Green MR, Kelsen DP, et al. Phase II trial of gemcitabine (2,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs 1994;12:29-34.
11. Abbruzzese JL, Grunewald R, Weeks EA, et al. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol 1991;9:491-498.
12. Burris HA, 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as firstline therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-2413.
13. Wong S, Oza A, Brierly J, et al. Phase I trial of Gemcitabine and escalating dose radiation therapy in patients with pancreatic carcinoma. Proc of ASCO 2000;19:abst # 1041.
14. Raben A, Mychalczak B, Brennan MF, et al. Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy. Int J Rad Oncol Biol Phys 1996;35:351-356.
15. Rich TA, Evans DB, Curley SA, et al. Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer. Ann of Oncol 1994;5:75-80.
16. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas [see comments]. J Clin Oncol 1997;15:928-937.
17. Koper PC, Stroom JC, van Putten WL, et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Rad Oncol Biol Phys 1999;43:727-734.
18. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999;353:267-272.
19. Higgins PD, Sohn JW, Fine RM, et al. Three-dimensional conformal pancreas treatment: comparison of four- to sixfield techniques. Int J Rad Oncol Biol Phys 1995;31:605-609.
20. Zelefsky MJ, Cowen D, Fuks Z, et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999;85:2460-2468.
21. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Rad Oncol Biol Phys 1998;41:491-500.
22. Hittelman W, Fujii T, Hunter N, et al. Identification of a window of therapeutic opportunity for the combination of gemcitabine and radiation. Proc Ann Meet Am Assoc Cancer Res 1996;37:A1973.
23. Milas L, Fujii T, Hunter N, et al. Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Research 1999;59:107-114.
24. Mason KA, Milas L, Hunter NR, et al. Maximizing therapeutic gain with gemcitabine and franctionated radiation. Int J Rad Oncol Biol Phys 1999;44:1125-1135.
25. Tempero M, Plunkett W, Ruiz V, et al. Randomized phase II trial of dose intense gemcitabine by standard infusion vs. fixed dose rate in metastatic pancreatic adenocarcinoma. Proc of ASCO 1999;18:Abst. #1048.
26. Wolff RA, Evans DB, Gravel DM, et al. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res 2001;7:2246-2253
27. Verhey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Sem Rad Oncol 1999;9:78-98.